30 results
8-K
EX-99.1
MIRO
Miromatrix Medical Inc.
14 Nov 23
Miromatrix Reports Third Quarter 2023 Results
4:05pm
for any future products we may seek to commercialize; our expectations regarding our manufacturing capabilities; a pandemic, epidemic or outbreak
SC 14D9
MIRO
Miromatrix Medical Inc.
13 Nov 23
Tender offer solicitation
7:01am
Product Candidate; and the impact of public health outbreaks, epidemics, or pandemics (such as the COVID-19 pandemic) on the Company’s business
SC TO-T
EX-99
MIRO
Miromatrix Medical Inc.
13 Nov 23
Third party tender offer statement
6:06am
;
any epidemic, pandemic or outbreak of disease (including, for the avoidance of doubt, COVID-19), or any escalation or worsening of such conditions
8-K
EX-2.1
MIRO
Miromatrix Medical Inc.
30 Oct 23
Tender and Support Agreement
6:12am
of the Code; or (vii) the application of any Pandemic Response Law.
(m) Neither the Company nor any of its Subsidiaries is a “United States real … or sought any benefit or relief with respect to Taxes pursuant to a Pandemic Response Law, (ii) is subject to a Tax holiday, Tax incentive or grant
8-K
EX-99.1
MIRO
Miromatrix Medical Inc.
14 Aug 23
Miromatrix Reports Second Quarter 2023 Results and Provides Corporate Update
4:01pm
products we may seek to commercialize; our expectations regarding our manufacturing capabilities; a pandemic, epidemic or outbreak of an infectious
8-K
EX-99.1
9x34ksca62q9n
1 Jun 23
Miromatrix Announces CEO Jeff Ross, Ph.D. will Expand His Role by Resuming Leadership of R&D
4:01pm
8-K
EX-99.1
r9juc 8fw
11 May 23
Miromatrix Reports First Quarter 2023 Results and Provides Corporate Update
4:01pm
8-K
EX-99.1
wu6txa8r io6acupc9
31 Mar 23
Miromatrix Reports Fourth Quarter and Full Year 2022 Results and Provides Corporate Update
4:01pm
8-K
EX-99.1
ba6kn 8mwaa9vim8ixx
15 Aug 22
Miromatrix Reports Second Quarter 2022 Results and Provides Corporate Update
4:07pm
8-K
EX-99.1
54tale co2f66m
16 May 22
Miromatrix Reports First Quarter 2022 Results and Provides Corporate Update
4:02pm
10-K
3q3emp3zy3
30 Mar 22
Annual report
4:34pm
8-K
EX-99.1
cpn8afwwvlcn
30 Mar 22
Miromatrix Reports Fourth Quarter and Full Year 2021 Results and Provides Corporate Update
4:13pm
8-K
EX-99.1
97asummjpcye0
1 Mar 22
Miromatrix Names Jim Douglas as New Chief Financial Officer
5:15pm
8-K
EX-99.1
tru09w19ffal143
5 Jan 22
Miromatrix Announces Two New Board Members
7:11am
8-K
EX-99.1
lq1kr
17 Dec 21
Miromatrix Submits Pre-IND Request to the FDA for Its External Liver Assist Product to Treat Acute Liver Failure
7:10am
8-K
EX-99.1
6gwja134og
15 Nov 21
Miromatrix Reports Third Quarter 2021 Results
4:15pm
8-K
EX-99.1
wlkkldvex bn61md8cx
7 Oct 21
Miromatrix Announces the First Successful Transplant of a Bioengineered Whole Organ in a Large Animal
6:04am